Brentuximab Vedotin and BeEAM High-dose Chemotherapy in Lymphomas
Clinical trial NCT03187210 · SUSPENDED
Trial details
- NCT number
- NCT03187210
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-01
- Primary completion
- 2023-11-02
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.